Literature DB >> 20592687

Vaccinia virus infection after sexual contact with a military smallpox vaccinee -Washington, 2010.

.   

Abstract

On March 1, 2010, the Washington State Department of Health (WADOH) notified Public Health - Seattle & King County (PHSKC) of a suspected case of contact transmission of vaccinia virus from sexual contact with a member of the military who had been vaccinated against smallpox. Vaccinia virus infection after sexual contact has been reported previously (1-4). Despite the patient's exposure history and clinical presentation, the diagnosis initially was not considered by the patient's physician, who ordered laboratory testing for several common sexually transmitted infections. The patient was seen by a second physician and referred to an infectious disease specialist, who obtained a swab sample of a genital lesion for laboratory testing for vaccinia virus. Vaccinia virus was confirmed by the Washington State Public Health Laboratory (WAPHL) and the CDC Poxvirus Laboratory. The patient resided in a household with an immunosuppressed renal transplant recipient. Appropriate contact precautions were recommended to the patient. No additional cases of contact transmission were reported. This report describes the patient's clinical course and the associated epidemiologic investigation. Health-care providers caring for U.S. military personnel or their contacts should consider vaccinia virus infection in the differential diagnosis of clinically compatible genital lesions. Contact precautions should be emphasized to all persons who are vaccinated, as well as their contacts with unexplained lesions that might represent vaccinia infection from contact transmission.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592687

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  5 in total

1.  Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Authors:  Richard N Greenberg; Edgar Turner Overton; David W Haas; Ian Frank; Mitchell Goldman; Alfred von Krempelhuber; Garth Virgin; Nicole Bädeker; Jens Vollmar; Paul Chaplin
Journal:  J Infect Dis       Date:  2012-12-07       Impact factor: 5.226

2.  Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice.

Authors:  Aklile Berhanu; David S King; Stacie Mosier; Robert Jordan; Kevin F Jones; Dennis E Hruby; Douglas W Grosenbach
Journal:  Vaccine       Date:  2010-10-29       Impact factor: 4.169

Review 3.  New challenges in human monkeypox outside Africa: A review and case report from Italy.

Authors:  Davide Mileto; Agostino Riva; Miriam Cutrera; Davide Moschese; Alessandro Mancon; Luca Meroni; Andrea Giacomelli; Giovanna Bestetti; Giuliano Rizzardini; Maria Rita Gismondo; Spinello Antinori
Journal:  Travel Med Infect Dis       Date:  2022-06-20       Impact factor: 20.441

4.  Secondary and tertiary transmission of vaccinia virus after sexual contact with a smallpox vaccinee--San Diego, California, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-01       Impact factor: 17.586

Review 5.  Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®).

Authors:  Danielle M Tack; Kevin L Karem; Jay R Montgomery; Limone Collins; Marthe G Bryant-Genevier; Rosemary Tiernan; Maria Cano; Paige Lewis; Renata J M Engler; Inger K Damon; Mary G Reynolds
Journal:  Hum Vaccin Immunother       Date:  2013-04-09       Impact factor: 4.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.